Comparison by Transoesophageal Assessement of Systolic Right Ventricle Function Measures in Perioperative Care of Pulmonary Transplant. (ETO VD PERIOP)

March 5, 2019 updated by: University Hospital, Strasbourg, France

The aim of the study is to describe the early adaptation of the right ventricle assessed by echocardiography to change of pulmonary circulation secondary to pulmonary transplantation.

Secondary objectives include change of haemodynamics measured by transpulmonary thermodilution and evolution of right heart function in terms of primary graft dysfunction grading.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

33

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Strasbourg, France, 67091
        • Strasbourg's New Civil Hospital, Cardiac surgical reanimation department

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult (over 18 years)
  • Patient affiliated to a social protection scheme insurance
  • Patient was informed of the study and w gave their consent
  • Patient on the lung transplant list
  • Patient eligible for a pulmonary transplantation after decision of a multidisciplinary team
  • Patients with chronic lung disease with parenchymal dysfunctions (Chronic obstructive pulmonary disease or COPD, alpha-1 antitrypsin deficiency, cystic fibrosis, pulmonary fibrosis, bronchiolitis obliterans organizing pneumonia or BOOP)

Exclusion Criteria:d

  • Minor patients
  • Patient under judicial protection, under guardianship
  • Patient in exclusion period (determined by a previous study or in progress)
  • Patient participating in parallel in another clinical trial that may interfere with the results of the study
  • Inability to give informed patient information (emergency, understanding difficulties, etc ...)
  • The refusal of patient consent
  • The use of cardiopulmonary bypass during lung transplantation
  • Uni-pulmonary transplant
  • A transplant for idiopathic or primary pulmonary hypertension
  • The presence of a cons-indication for transesophageal echocardiography:

    o Absolute contraindications:

  • Abnormalities of the esophagus: stenosis, tumor, diverticulum perforation, active bleeding

    o Relative contraindications:

  • ancient cervicothoracic irradiation history (> 10 years)
  • recent upper gastrointestinal bleeding history
  • presence of esophageal varices ≥ grade II
  • zero cervical mobility
  • Reflux Esophagitis
  • Severe coagulation disorders
  • Pregnancy / Breastfeeding

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: All patient
Only one arm has been specified for the protocol. This arm included all study patient (33) for which the intervention is to be administered

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Transesophageal echocardiographic assessment for comparision of right ventricle free-wall strain rate in perioperative care of bipulmonary transplantation
Time Frame: Outcome is measured 3 times : after induction of general anesthesia, before surgical incision, after throacic closure and 6 to 12 hours postoperative.
Outcome is measured 3 times : after induction of general anesthesia, before surgical incision, after throacic closure and 6 to 12 hours postoperative.
Transesophageal echocardiographic assessment for comparision of right ventricle isovolumic acceleration in perioperative care of bipulmonary transplantation
Time Frame: utcome is measured 3 times : after induction of general anesthesia, before surgical incision, after throacic closure and 6 to 12 hours postoperative.
utcome is measured 3 times : after induction of general anesthesia, before surgical incision, after throacic closure and 6 to 12 hours postoperative.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gharib Ajob, MD, Strasbourg's University Hospitals

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 5, 2016

Primary Completion (Actual)

February 20, 2018

Study Completion (Actual)

February 27, 2018

Study Registration Dates

First Submitted

June 20, 2016

First Submitted That Met QC Criteria

August 29, 2016

First Posted (Estimate)

September 2, 2016

Study Record Updates

Last Update Posted (Actual)

March 7, 2019

Last Update Submitted That Met QC Criteria

March 5, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 6283

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Primary Lung Graft Dysfunction

Clinical Trials on transoesophageal echocardiography

3
Subscribe